EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Liubao Tea Extract Attenuates High-Fat Diet and Streptozotocin-Induced Type 2 Diabetes in Mice by Remodeling Hepatic Metabolism and Gut Microbiota

Jichu Luo, Zhijuan Wei, Yuru Tan, Ying Tong, Bao Yang iD, Mingsen Wen, Xuan Guan, Pingchuan Zhu iD, Song Xu, Xueting Lin, Qisong Zhang iD

Nutrients · 2025

DOI: 10.3390/nu17162665 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Jichu Luo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Key Laboratory of Special Biomedicine, School of Medicine, Guangxi University, Nanning 530004, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Diet, High-Fat, Liver, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Guangxi, Guangxi Key R&D Program, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Type 2 diabetes (T2D) has become a serious global public health concern. Liubao tea (LBT) has demonstrated beneficial effects on gut microbiota and glucose-lipid metabolism, holding promising therapeutic potential for T2D; however, its underlying mechanisms remain unclear. This study aims to elucidate the potential mechanisms of Liubao tea extract (LBTE) against T2D.

Methods

LC-MS technology was used to identify the chemical components of LBTE and combined with network pharmacology and molecular docking to screen its potential active ingredients and targets for improving T2D. Therapeutic efficacy was assessed in high-fat diet/streptozotocin (HFD/STZ)-induced diabetic mice via serum biochemical analyses and histopathological examinations. Serum metabolomics, 16S rRNA sequencing, quantification of short-chain fatty acids (SCFAs), quantitative real-time PCR (qPCR), and antibiotic-treated pseudo-germ-free models were employed to elucidate the underlying mechanisms.

Results

LBTE effectively reduced blood glucose levels and improved lipid metabolism, primarily by promoting hepatic glycogen synthesis and suppressing glycerophospholipid synthesis. LBTE also alleviated hepatic inflammation by modulating inflammatory cytokine expression. Additionally, LBTE reshaped the gut microbiota profiles by decreasing harmful bacteria and increasing SCFA-producing bacteria, resulting in elevated fecal SCFAs. SCFAs contributed to improving hepatic metabolism and inflammation, enhancing intestinal barrier function. Notably, these effects were abolished by antibiotic-induced microbiota depletion, confirming the microbiota-dependent mechanism of LBTE. Quercetin, luteolin, genistein, and kaempferol were considered as potential active ingredients contributing to the antidiabetic effects of LBTE.

Conclusions

These findings provide novel perspectives on the viability of LBTE as a complementary strategy for T2D prevention and management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeDiet, High-FatLiverDiabetes Mellitus, Type 2Diabetes Mellitus, ExperimentalPlant ExtractsTeaAnimalsMiceMaleLipid MetabolismMice, Inbred C57BLStreptozocinBlood GlucoseFatty Acids, Volatile

Stichwörter der Autor:innen

Liubao tea extractgut microbiotahepatic metabolismshort-chain fatty acidstype 2 diabetes

Substanzen

Plant ExtractsTeaStreptozocinBlood GlucoseFatty Acids, Volatile

Autor:innen und Institutionen

  • Guangxi Key Laboratory of Special Biomedicine, School of Medicine, Guangxi University, Nanning 530004, China.
  • Hubei Provincial Key Laboratory of Occurrence and Intervention of Rheumatic Diseases, Hubei Minzu University, Enshi 445000, China.
  • State Key Laboratory for Conservation and Utilization of Subtropical Agro-Bioresources, Guangxi University, Nanning 530004, China.
  • Center for Instrumental Analysis, Guangxi University, Nanning 530004, China.

ORCID-Profile: Bao Yang, Pingchuan Zhu, Qisong Zhang

Förderung

  • Natural Science Foundation of Guangxi
  • Guangxi Key R&D Program
  • National Natural Science Foundation of China
  • Guangxi Zhuang Autonomous Region Administration of Traditional Chinese Medicine
  • Guangxi Science and Technology Major Program
  • Hubei Key Laboratory of Rheumatic Disease Occurrence and Intervention
  • Guangxi Key R&D Program Projects
  • Hubei Provincial Key Laboratory of Occurrence and Intervention of Rheumatic Diseases

Zitieren

APA

Luo, J., Wei, Z., Tan, Y., Tong, Y., Yang, B., Wen, M., Guan, X., Zhu, P., Xu, S., Lin, X., & Zhang, Q. (2025). Liubao Tea Extract Attenuates High-Fat Diet and Streptozotocin-Induced Type 2 Diabetes in Mice by Remodeling Hepatic Metabolism and Gut Microbiota. Nutrients. https://doi.org/10.3390/nu17162665

Vancouver

Luo J, Wei Z, Tan Y, Tong Y, Yang B, Wen M, et al. Liubao Tea Extract Attenuates High-Fat Diet and Streptozotocin-Induced Type 2 Diabetes in Mice by Remodeling Hepatic Metabolism and Gut Microbiota. Nutrients. 2025. doi:10.3390/nu17162665

BibTeX
@article{Luo2025,
  author = {Luo, Jichu and Wei, Zhijuan and Tan, Yuru and Tong, Ying and Yang, Bao and Wen, Mingsen and Guan, Xuan and Zhu, Pingchuan and Xu, Song and Lin, Xueting and Zhang, Qisong},
  title = {Liubao Tea Extract Attenuates High-Fat Diet and Streptozotocin-Induced Type 2 Diabetes in Mice by Remodeling Hepatic Metabolism and Gut Microbiota},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17162665}
}
Kostenlos starten →